PROVENTION BIO INC's ticker is PRVB and the CUSIP is 74374N102. A total of 118 filers reported holding PROVENTION BIO INC in Q2 2022. The put-call ratio across all filers is 0.36 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $657,183 | +467.3% | 27,269 | +148.8% | 0.00% | – |
| Q4 2022 | $115,847 | -99.9% | 10,960 | -49.1% | 0.00% | – |
| Q3 2022 | $96,826,000 | +45.1% | 21,517 | +29.0% | 0.00% | – |
| Q2 2022 | $66,708,000 | +65.3% | 16,677 | +202.6% | 0.00% | – |
| Q1 2022 | $40,348,000 | -62.8% | 5,512 | -71.4% | 0.00% | – |
| Q4 2021 | $108,370,000 | +29.3% | 19,283 | +47.3% | 0.00% | – |
| Q3 2021 | $83,789,000 | +45.9% | 13,092 | +92.1% | 0.00% | – |
| Q2 2021 | $57,442,000 | -20.1% | 6,814 | -0.5% | 0.00% | – |
| Q1 2021 | $71,880,000 | -53.7% | 6,849 | -25.2% | 0.00% | – |
| Q4 2020 | $155,187,000 | +8.4% | 9,161 | -17.9% | 0.00% | – |
| Q3 2020 | $143,119,000 | +529.6% | 11,155 | +592.4% | 0.00% | – |
| Q2 2020 | $22,731,000 | – | 1,611 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DG Capital Management, LLC | 417,092 | $5,351,000 | 3.22% |
| Johnson & Johnson Innovation - JJDC, Inc. | 574,973 | $7,377,000 | 1.48% |
| Soleus Capital Management, L.P. | 139,418 | $1,789,000 | 0.95% |
| 683 Capital Management, LLC | 859,314 | $11,025,000 | 0.81% |
| Perceptive Advisors | 4,265,711 | $54,729,000 | 0.80% |
| GILDER GAGNON HOWE & CO LLC | 2,151,402 | $27,602,000 | 0.17% |
| Virtus ETF Advisers LLC | 21,485 | $276,000 | 0.14% |
| RICE HALL JAMES & ASSOCIATES, LLC | 230,873 | $2,962,000 | 0.12% |
| Windsor Creek Advisors, LLC | 28,492 | $366,000 | 0.10% |
| Newbridge Financial Services Group, Inc. | 6,500 | $83,000 | 0.08% |